期刊文献+

Gli1和OPN在结直肠癌组织中的表达及其临床意义 被引量:3

Expression and Clinical Significance of Gli1 and OPN in Colorectal Cancer
下载PDF
导出
摘要 目的探讨脑胶质瘤相关癌基因(glioma-associated oncogene1,Gli1)和骨桥蛋白(osteopontin,OPN)在结直肠癌组织中的表达情况及临床意义。方法应用免疫组化SP法检测Gli1和OPN蛋白在76例结直肠癌组织,23例正常结直肠组织中的表达情况,分析Gli1和OPN与结直肠癌患者的临床病理因素之间的关系以及二者之间表达的相关性。结果 (1)Gli1在结直肠癌组织和正常结肠组织中表达的阳性率分别为43.4%(33/76)和13.0%(3/23),两者差异具有统计学意义(P<0.05);OPN在结直肠癌组织和正常结肠组织中表达的阳性率分别为51.3%(39/76)和17.4%(4/23),差异有统计学意义(P<0.05)。(2)Spearman等级相关分析提示,Gli1和OPN在结直肠癌组织间的表达呈正相关(r=0.312,P<0.01)。结论 Gli1和OPN参与了结直肠癌的发生发展过程,二者之间可能起协同作用,联合检测Gli1和OPN对于评估结直肠癌的生物学特性和判断预后具有一定价值。 Objective To investigate the expression and clinicopathologieal significance of Glil and OPN protein in colorectal cancer and normal colorectal tissues. Methods Immunohistochemistry SP method was used to detect the expression of Glil and OPN in 76 cases of colorectal cancer tissues and 23 normal colorectal tissues, and analyze the relationship between the expression and clinicopathological parameters, and the correlation between Glil and OPN expression. Results (1) The expression of Glil in colorectal cancer tissues and normal colorectal tissues were 43.4% (33/76) and 13.0% ( 3/23 ) , The expression of Glil in colorectal cancer tissues and normal colorectal tissues were 51.3% (39/76) and 17.4% (4/23). Both difference had statistical significance ( P 〈 0.05 ). ( 2 ) Positive relation was seen between the expression of Glil and OPN by Spearman analyze. Conclusion Glil and OPN were involved in the tumorigenesis and development of colorectal cancer. They might play a synergetic effect in the process. The joint detection of Glil and OPN might be regarded as much value to evaluate the biological features and judge the prognosis of colorectal cancer.
出处 《医学研究杂志》 2014年第6期135-137,共3页 Journal of Medical Research
基金 杭州市科技局引导项目
关键词 结直肠癌 GLI1 免疫组织化学 Colorectal cancer Glil OPN Immunohistochemistry
  • 相关文献

参考文献10

  • 1程洪艳,刘亚南,叶雪,昌晓红,成夜霞,崔恒.血清人附睾分泌蛋白4(HE_4)和CA_(125)在卵巢癌患者手术及化疗前后的变化[J].中国妇产科临床杂志,2011,12(3):212-215. 被引量:43
  • 2Yoon JW,Kita Y,Frank DJ,et al.Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation[J].J Biol Chem,2002,277(7):5548-5555.
  • 3Qualtrough D,Buda A,Gaffield W,et al.Hedgehog signalling in colorectal tumour cells:induction of apoptosis with cyclopamine treatment[J].Int J Cancer,2004,110(6):831-837.
  • 4Chatel G,Ganeff C,Boussif N,et al.Hedgehog signaling pathway is inactive in colorectal cancer cell lines[J].Int J Cancer,2007,121(12):2622-2627.
  • 5Ingham PW.Transducing Hedgehog:the story so far.[J].EMBO J,1998,17(13):3505-3511.
  • 6Wang H,Li YY,Wu YY,et al.Expression and clinical significance of hedgehog signaling pathway related components in colorectal cancer[J].Asian Pac J CancerPrev,2012,13(5):2319-2324.
  • 7Akiyoshi T,Nakamura M,Koga K,et al.Gli1,downregulated in colorectal cancers,inhibits proliferation of colon cancer cells involving Wnt signalling activation[J].Gut,2006,55 (7):991-999.
  • 8Li KW,Hong W,Shu WZ,et al.The potential of osteopontin as a therapeutic target for human colorectal cancer[J].J Gastrointest Surg,2011,15(4):652-659.
  • 9Li KW,Hong W,Shu WZ.Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer[J].J Gastrointest Surg,2010,14(1):74-81.
  • 10Das S,Harris LG,Metge BJ,et al.The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin[J].J Biol Chem,2009,284 (34):22888-22897.

二级参考文献18

  • 1Moore RG,Mcmeekin DS,Brown AK,et al.A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.Gynecol Oncol,2009,112:40-46.
  • 2Hellstrom(o) I,Hellstrom KE SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other.Adv Exp Med Biol,2008,622:15-21.
  • 3Bast Jr RC,Feeney M,Lazarus H,et al.Reactivity of amonoclonal antibody with human ovarian carcinoma.J Clin Invest,1981,68:1331-1337.
  • 4Kabawat SE,Bast RC Jr,Bhan AK,et al.Tissue distribution of a coelomic epithelium-related antigen recognized by the monoclonal antibody OC 125.Int J Gynecol Pathol,1983,2:275-285.
  • 5Riedinger JM,wafnart J,Rieolleau G,et al.CA125 halflife and CA125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome:results of a French muhicemrie study.Annas of Oncology,2006,17:1234-1238.
  • 6Riedinger JM,Bonnetain F,Eche N,et al.Prognostic value of CA125 half-life and early normalization during chemotherapy in advanced ovarian tumors:results of a muhicentric.French study Bull Cancer,2007,94:287-295.
  • 7Kim HS,Park NH,Chung HH,et al.Serum CA125 levelafter 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responderK survival in patients with advanced epithelial ovarian cancer.Onkologie,2008,31:315-320.
  • 8Rustin GJ,Marples M,Nelstmp AE,et al.Use of CA125to define progression of ovarian cancer in patients with persistently elevated levels.J Clin Oncol,2001,19:4054-4057.
  • 9Nyvang GB,Mogensen O,Bichel P,et al.Combined prognostic importance of CA125,histopathologic grade and DNAindex in advanced ovarian cancer.Eur J Gynaecol Oncol,2000,21:569-572.
  • 10Low RN,Saleh F,Song SY,et al.Treated ovarian cancer:comparison of MR imaging with serum CA-125 level and physical examination-A longitudinal studyRadiology,1999,211:519-528.

共引文献42

同被引文献31

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部